Concepedia

Robert Venuti

RV

9

Publications

328

Citations

9

H-Index

1992

Active since

Affiliations

Aurobindo Pharma (United States)(Current)

New Frontier

University of Cincinnati

Robert Venuti is an author at Aurobindo Pharma (United States) specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

1992–2020

9

Publications

9

A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin.

Gary K. Schwartz, David Ward, Leonard B. Saltz et al. · PubMed · 1997 · 104 citations

, , +17

Carvedilol: A Novel Cardiovascular Drug with Multiple Actions

Robert Ruffolo, Duane A. Boyle, David P. Brooks et al. · Cardiovascular Drug Reviews · 1992 · 65 citations

, , +6

A Phase 2A Dose-Escalation Study of the Safety, Tolerability, Pharmacokinetics and Haemodynamic Effects of BMS-986231 in Hospitalized Patients with Heart Failure with Reduced Ejection Fraction

Cristina Tita, Edward M. Gilbert, Adrian B. Van Bakel et al. · European Journal of Heart Failure · 2017 · 54 citations · Full text

Preclinical and clinical pharmacology of carvedilol.

R R Ruffolo, D A Boyle, Robert Venuti et al. · PubMed · 1993 · 26 citations

A PHASE 1 STUDY OF THE SAFETY AND PHARMACOKINETICS OF THE INTRAVENOUS NITROXYL PRODRUG, CXL-1427

D. Cowart, Robert Venuti, Jeffrey T. Guptill et al. · Journal of the American College of Cardiology · 2015 · 19 citations

, , +3

Rows per page

1–5 of 9